Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SNA International is a private U.S. company that provides forensic science, biometrics, identity intelligence, public health preparedness, and related technology services primarily to government customers. Founded in 2002 and headquartered in Alexandria, Virginia, the company combines biological science, physical science, and IT capabilities to support high-consequence missions such as human identification, mass fatality response, genealogy, Rapid DNA implementation, and laboratory support. Its best-known product appears to be DNAConnect, a forensic DNA information management platform designed to support Rapid DNA casework and compliance workflows. SNA also performs service-based work spanning forensic pathology, DNA, toxicology, epidemiology, emergency planning, and mission support for defense, homeland security, and public safety agencies. While it has biotechnology and public health capabilities, it is not a traditional therapeutics biotech or biopharma company with a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SNA International.